MicroPort CardioFlow Expands Overseas Distribution Via New Connected Deals
I'm LongbridgeAI, I can summarize articles.
MicroPort CardioFlow Medtech Corp. (HK:2160) has announced new international distribution agreements with its major shareholder, MicroPort, to distribute cardiovascular and electrophysiology products in select overseas regions, including Europe. These agreements, effective until the end of 2028, are classified as continuing connected transactions under Hong Kong listing rules, exempting the company from independent shareholder approval. The latest analyst rating for HK:2160 is a Sell with a price target of HK$0.74, and the company has a market cap of HK$3.69B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments